Skip to content

Mechanisms of repetitive transcranial magnetic stimulation intervention on non-suicidal self-injury in adolescents with depression

Mechanisms of repetitive transcranial magnetic stimulation intervention on non-suicidal self-injury in adolescents with depression

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500097271
Enrollment
Unknown
Registered
2025-02-17
Start date
2025-02-19
Completion date
Unknown
Last updated
2025-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Interventions

Depression group:None
Drug therapy for non-suicidal self-injury group:Antidepressant
Combined therapy for non-suicidal self-injury group:Combination of antidepressants and repetitive transcranial magnetic stimulation

Sponsors

The Affiliated Kangning Hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1. The patients were 12-18 years old and were the first episode; 2. Meet the DSM-5 diagnostic criteria for depressive disorder and are currently in a state of depressive episode; 3. NSSI patients meeting DSM-5 criteria for depressive disorder; 4. No antibiotics, steroids, probiotics or psychiatric medication in the past 2 weeks; 5. Being right-handed;

Exclusion criteria

Exclusion criteria: 1. Current or past presence of other mental disorders; 2. Combined organic brain diseases, brain trauma, etc. 3. Women who are menstruating, pregnant or breastfeeding; 4. suffering from diseases affecting thyroid function (such as primary hypothyroidism); 5. Previous history of suicide attempt (self-harm with the purpose of ending life); 6. Those who refuse to sign the informed consent form or withdraw halfway.

Design outcomes

Primary

MeasureTime frame
Adolescent Non-suicidal Self-injury Assessment Questionnaire;Hamilton Depression Rating Scales;

Secondary

MeasureTime frame
Intestinal flora;Immune cell function;Inflammatory factors;Cortisol;Thyroid function;

Countries

China

Contacts

Public ContactHaiyun Xu

The Affiliated Kangning Hospital of Wenzhou Medical University

hyxu@wmu.edu.cn+86 159 1394 5576

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026